ORBIT Bleeding Score Calculator

Clinical calculation support · Verify results before clinical use

Bleeding risk assessment

Select each clinical feature present. The score updates automatically.

0Score / 7
1

Older age (75 years or older)

Age ≥75 years.

+1 point
2

Reduced hemoglobin or anemia

Hemoglobin <13 g/dL in men or <12 g/dL in women, reduced hematocrit, or a history of anemia.

+2 points
3

History of bleeding

Previous bleeding history as defined in the ORBIT score derivation study.

+2 points
4

Impaired kidney function

Estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m².

+1 point
5

Concurrent antiplatelet therapy

Current treatment with an antiplatelet agent.

+1 point
0ORBIT
Estimated major bleeding risk category
Low risk
Approximately 2.4 major bleeds per 100 patient-years in the low-risk group (score 0–2).
Clinical interpretation Use the score to identify potentially modifiable bleeding risk factors; interpret it in the context of the patient's overall clinical situation.

The published rates are observed group-level rates per 100 patient-years, not an individualized prediction or a guarantee of an individual patient's annual risk.

About the ORBIT score

The ORBIT bleeding score was developed to estimate major bleeding risk in patients with atrial fibrillation receiving oral anticoagulation. It uses five clinical factors that are generally available in routine care.

Components and points

FactorCriterionPoints
Older ageAge ≥75 years1
Reduced hemoglobin / anemiaLow hemoglobin/hematocrit or history of anemia2
Bleeding historyHistory of bleeding2
Impaired kidney functioneGFR <60 mL/min/1.73 m²1
Antiplatelet treatmentConcurrent antiplatelet therapy1

Risk categories in the derivation cohort

ScoreCategoryObserved major bleeding rate
0–2Low2.4 per 100 patient-years
3Medium4.7 per 100 patient-years
4–7High8.1 per 100 patient-years

Clinical use and limitations

ORBIT supports bleeding-risk assessment but should not be used alone to decide whether to start or withhold oral anticoagulation. Assess modifiable risk factors, drug interactions, renal function, anemia, prior bleeding, and the patient's thromboembolic risk and preferences.

References

O’Brien EC, Simon DN, Thomas LE, et al. The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation. European Heart Journal. 2015;36(46):3258–3264. doi:10.1093/eurheartj/ehv476
Joglar JA, Chung MK, Armbruster AL, et al. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation. Journal of the American College of Cardiology. 2024;83(1):109–279. doi:10.1016/j.jacc.2023.08.017
Clinical disclaimer: This calculator is an educational aid and does not replace clinical judgement. Bleeding-risk scores should be used to identify and address modifiable risk factors, not in isolation to determine eligibility for anticoagulation. Apply the score in the appropriate patient population and consult current guidance.